Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces the launch of the Prolaris + AI Test at the end of this month. Prolaris will be the ...

Tempus AI is expanding its clinical oncology offering with the launch of ArteraAI Prostate Test for metastatic hormone-sensitive prostate cancer. ・The tool combines digital pathology and genomic ...

The ArteraAI Prostate Test (mHSPC) is the first externally developed digital pathology algorithm being made clinically available through the Tempus ecosystem. This AI-powered test assesses a patient's ...

AstraZeneca and Roche Diagnostics Asia Pacific today announced a three-year Memorandum of Understanding to help advance ...

Your pathology report includes vital information about your brain tumor that can guide treatment. Get to know how to interpret common terms.

AI tools designed to diagnose cancer from tissue samples are quietly learning more than just disease patterns. New research shows these systems can infer patient demographics from pathology slides, ...

Blood-based markers that could improve early, less invasive detection of inflammatory breast cancer, or IBC, were identified ...

New AI tool brings precision pathology for cancer and beyond into quicker, sharper focus by Perelman School of Medicine at the University of Pennsylvania Editors' notes ...

In a recent study published in Cancers, researchers comprehensively summarized all available information about B cells in the context of breast cancer. In addition, they explored their clinical ...

Pancreatic cancer has historically been one of the toughest diagnoses to face, largely because it is difficult to catch early ...

The Department of Pathology, Hospital Escuela Oscar Danilo Rosales Argüello (HEODRA), León, Nicaragua, decided to introduce and implement synoptic reporting for all cancer cases beginning in 2018. All ...